Inactive Instrument

Analyst Reco. Home Point Capital Inc.

Equities

HMPT

US43734L1061

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

Credit Suisse Downgrades Home Point Capital to Neutral From Outperform on Heels of Announced Sale to Mr. Cooper Group, Lowers PT to $2.33 From $2.50	23-05-12	MT
Morgan Stanley Adjusts Price Target on Home Point Capital to $2.35 From $1.25, Maintains Equal-Weight Rating	23-05-11	MT
Goldman Sachs Adjusts Price Target on Home Point Capital to $1.50 From $1.35, Maintains Sell Rating	23-03-14	MT
Wedbush Lifts Home Point Capital's PT to $2 From $1.50, Raises Estimates Owing to Lower Amortization, Operating Expense Assumptions; Keeps Neutral Rating	23-03-10	MT
Morgan Stanley Adjusts Price Target on Home Point Capital to $1.25 From $3.50, Maintains Equal-Weight Rating	22-12-16	MT
UBS Adjusts Home Point Capital Price Target to $2 From $3.50, Maintains Neutral Rating	22-11-22	MT
Credit Suisse Trims Home Point Capital's PT to $3.50 From $4 to Reflect Continued Challenging Environment, Keeps Outperform Rating	22-11-21	MT
Wedbush Trims Home Point Capital's PT to $1.50 From $4, Expects to Remain Unprofitable Until Spring 2023 Selling Season; Keeps Neutral Rating	22-11-11	MT
Piper Sandler Adjusts Price Target on Home Point Capital to $3 From $3.50, Maintains Neutral Rating	22-09-30	MT
Wedbush Cuts Home Point Capital to Neutral From Outperform, PT to $4 From $5.50, Says Competitive Pricing Pressures, Higher Expense Make Company Less Attractive Takeout Target	22-08-15	MT
UBS Adjusts Home Point Capital Price Target to $3.50 From $4.50, Maintains Neutral Rating	22-05-23	MT
Wedbush Adjusts Home Point Capital Price Target to $5.50 From $4, Maintains Outperform Rating	22-05-18	MT
JMP Securities Downgrades Home Point Capital to Market Perform From Market Outperform	22-04-13	MT
Goldman Sachs Trims Home Point Capital's Price Target to $3 From $3.60, Maintains Sell Rating	22-04-04	MT
Credit Suisse Lowers Home Point Capital's PT to $6.50 from $8 to Reflect Lower Earnings, Keeps Outperform Rating	22-02-25	MT
Wedbush Cuts Home Point Capital's Price Target to $5.50 From $8 After Q4 Adjusted EPS Miss; Outperform Rating Kept	22-02-25	MT
Wells Fargo Downgrades Home Point Capital to Equalweight From Overweight, Adjusts Price Target to $4 From $6	22-02-25	MT
BofA Securities Adjusts Home Point Capital's Price Target to $4 from $5, Maintains Underperform Rating	22-02-22	MT
JPMorgan Double Downgrades Home Point Capital to Underweight From Overweight; Shares Drop 2% Premarket	22-01-19	MT
Goldman Sachs Downgrades Home Point Capital to Sell From Neutral; Price Target is $4.50	22-01-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Home Point Capital Inc.

Equities

HMPT

US43734L1061

Analyst Reco.

Filters